Skip to main content
Fig. 4 | Cardiovascular Diabetology

Fig. 4

From: Effect of SGLT2 inhibitors on body composition, fluid status and renin–angiotensin–aldosterone system in type 2 diabetes: a prospective study using bioimpedance spectroscopy

Fig. 4

Overhydration (OH; a), L/1.73 m2 and extracellular water (ECW; b), L/1.73 m2 in healthy controls, hypertensive patients with and without hydrochlorothiazide and in patients with type 2 diabetes with and without SGLT2 inhibitor. Values reported for patients with type 2 diabetes with SGLT2 inhibitor are values measured at the end of follow up period (day 180 of medication with SGLT2 inhibitor). Hypertensive patients with hydrochlorothiazide (HCT) have taken hydrochlorothiazide for at least 6 months. ANOVA analysis and t-tests performed for each pair reveal no difference in OH or ECW of patients with type 2 diabetes with SGLT2 inhibitors compared to healthy controls, patients with type 2 diabetes without SGLT2 inhibitor and hypertensive patients with and without hydrochlorothiazide. Whiskers indicate median and interquartile range

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840